News about Drug Discovery & Development

Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research

Through this collaboration, Astellas is committed to strengthening translational science and clinical research in order to deliver innovative new medicines.

Drug Discovery & Development | 04/04/2025 | By Aishwarya |  433

Redwire Secures NASA Contract to Expand Pharmaceutical Drug Development in Space

With 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules.

Drug Discovery & Development | 28/03/2025 | By Aishwarya |  415

Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Drug Discovery & Development | 26/03/2025 | By Aishwarya |  484

ENTOD Pharma Unveils Advanced Veterinary Ear Drops to Combat Ear Mites in Pets

This launch marks ENTOD Pharmaceuticals' continued commitment to innovating in veterinary eye and ear care solutions under its specialised FUR by ENTOD (Veterinary) division.

Drug Discovery & Development | 26/03/2025 | By Aishwarya |  600

TUL Signs Exclusive License Deal with Novo Nordisk for UBT251

Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251.

Drug Discovery & Development | 25/03/2025 | By Aishwarya |  529

Everest Medicines Receives FDA Clearance of IND Application for EVM14

EVM14 is an off-the-shelf mRNA cancer vaccine targeting multiple TAAs and is designed to treat various cancers, including non-small cell lung cancer and head and neck cancer.

Drug Discovery & Development | 24/03/2025 | By Aishwarya |  696

Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering Cancer Center

Actinium Pharmaceuticals has entered a research collaboration with Memorial Sloan Kettering Cancer Center to expand Actimab-A’s mutation-agnostic mechanism in AML through targeted therapy combinations and patient-derived models.

Drug Discovery & Development | 20/03/2025 | By Aishwarya |  262

Nexus Pharmaceuticals Launches Tranexamic Acid

This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most.

Drug Discovery & Development | 20/03/2025 | By Aishwarya |  480

Akeso Gets NMPA Approval of Penpulimab for Nasopharyngeal Cancer

With this new approval, penpulimab now provides comprehensive treatment coverage across all stages of NPC, offering patients a continuous immunotherapy option from first-line to third-line therapy.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  545

LGM Pharma Invests USD 6 Million in US Drug Manufacturing Facility

The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug products, addressing the rising demand for reliable US-based production.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  411